PHLPP1 antibody
Quick Overview for PHLPP1 antibody (ABIN2764065)
Target
See all PHLPP1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human
-
Characteristics
- KIAA0606, PHLPP, PLEKHE1, SCOP, PHLPP1, PH domain leucine-rich repeat-containing protein phosphatase 1, Pleckstrin homology domain-containing family E member 1, Suprachiasmatic nucleus circadian oscillatory protein,PHLPP1 is a 1717 aa protein with phosphatase activity that mediates dephosphorylation of 'Ser-473' of AKT1, 'Ser-660' of PRKCB isoform beta-II and 'Ser-657' of PRKCA. AKT1 regulates the balance between cell survival and apoptosis through a cascade that primarily alters the function of transcription factors that regulate pro- and antiapoptotic genes. Dephosphorylation of 'Ser-473' of AKT1 triggers apoptosis and suppression of tumor growth. Controls the phosphorylation of AKT2 and AKT3 more efficiently than that of AKT1. Dephosphorylation of PRKCA and PRKCB leads to their destabilization and degradation. Inhibits cancer cell proliferation and may act as a tumor suppressor. May act as a negative regulator of K-Ras signaling in membrane rafts.
-
Purification
- Antigen Immunoaffinity Purification
-
Immunogen
- Synthetic peptide derived from the human PHLPP1 protein
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal concentration should be evaluated by serial dilutions.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Provided as solution in phosphate buffered saline with 0.08 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles
-
-
- PHLPP1 (PH Domain and Leucine Rich Repeat Protein Phosphatase 1 (PHLPP1))
-
Alternative Name
- PH Domain-containing family E member 1
-
UniProt
- O60346
-
Pathways
- PI3K-Akt Signaling, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway
Target
-